vs
汉美驰（HBB）与LifeStance Health Group, Inc.（LFST）财务数据对比。点击上方公司名可切换其他公司
LifeStance Health Group, Inc.的季度营收约是汉美驰的1.8倍（$382.2M vs $212.9M），汉美驰净利率更高（8.7% vs 3.1%，领先5.7%），LifeStance Health Group, Inc.同比增速更快（17.4% vs -0.3%），LifeStance Health Group, Inc.自由现金流更多（$46.6M vs $27.9M），过去两年汉美驰的营收复合增速更高（28.8% vs 12.8%）
汉美驰品牌控股公司是美国家电与商用餐厨设备设计营销企业，核心业务覆盖美加墨地区，主要推出搅拌机、料理机、烤面包机、慢炖锅、电熨斗、空气净化器等家用及商用设备，在北美家电市场拥有较高知名度。
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
HBB vs LFST — 直观对比
营收规模更大
LFST
是对方的1.8倍
$212.9M
营收增速更快
LFST
高出17.7%
-0.3%
净利率更高
HBB
高出5.7%
3.1%
自由现金流更多
LFST
多$18.7M
$27.9M
两年增速更快
HBB
近两年复合增速
12.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $212.9M | $382.2M |
| 净利润 | $18.5M | $11.7M |
| 毛利率 | 28.3% | — |
| 营业利润率 | 11.9% | 4.7% |
| 净利率 | 8.7% | 3.1% |
| 营收同比 | -0.3% | 17.4% |
| 净利润同比 | -22.7% | 264.1% |
| 每股收益（稀释后） | $1.37 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HBBLFST
| Q4 25 | $212.9M | $382.2M | ||
| Q3 25 | $132.8M | $363.8M | ||
| Q2 25 | $127.8M | $345.3M | ||
| Q1 25 | $133.4M | $333.0M | ||
| Q4 24 | $213.5M | $325.5M | ||
| Q3 24 | $156.7M | $312.7M | ||
| Q2 24 | $156.2M | $312.3M | ||
| Q1 24 | $128.3M | $300.4M |
净利润HBBLFST
| Q4 25 | $18.5M | $11.7M | ||
| Q3 25 | $1.7M | $1.1M | ||
| Q2 25 | $4.5M | $-3.8M | ||
| Q1 25 | $1.8M | $709.0K | ||
| Q4 24 | $24.0M | $-7.1M | ||
| Q3 24 | $1.9M | $-6.0M | ||
| Q2 24 | $6.0M | $-23.3M | ||
| Q1 24 | $-1.2M | $-21.1M |
毛利率HBBLFST
| Q4 25 | 28.3% | — | ||
| Q3 25 | 21.1% | — | ||
| Q2 25 | 27.5% | — | ||
| Q1 25 | 24.6% | — | ||
| Q4 24 | 26.1% | — | ||
| Q3 24 | 28.0% | — | ||
| Q2 24 | 25.9% | — | ||
| Q1 24 | 23.4% | — |
营业利润率HBBLFST
| Q4 25 | 11.9% | 4.7% | ||
| Q3 25 | 2.2% | 2.0% | ||
| Q2 25 | 4.7% | -0.9% | ||
| Q1 25 | 1.7% | 0.5% | ||
| Q4 24 | 11.0% | 0.3% | ||
| Q3 24 | 6.8% | 0.0% | ||
| Q2 24 | 6.4% | -5.1% | ||
| Q1 24 | -0.7% | -5.6% |
净利率HBBLFST
| Q4 25 | 8.7% | 3.1% | ||
| Q3 25 | 1.2% | 0.3% | ||
| Q2 25 | 3.5% | -1.1% | ||
| Q1 25 | 1.4% | 0.2% | ||
| Q4 24 | 11.2% | -2.2% | ||
| Q3 24 | 1.2% | -1.9% | ||
| Q2 24 | 3.8% | -7.5% | ||
| Q1 24 | -0.9% | -7.0% |
每股收益（稀释后）HBBLFST
| Q4 25 | $1.37 | — | ||
| Q3 25 | $0.12 | — | ||
| Q2 25 | $0.33 | — | ||
| Q1 25 | $0.13 | — | ||
| Q4 24 | $1.72 | — | ||
| Q3 24 | $0.14 | — | ||
| Q2 24 | $0.42 | — | ||
| Q1 24 | $-0.08 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $47.3M | $248.6M |
| 总债务越低越好 | $50.0M | $282.8M |
| 股东权益账面价值 | $182.8M | $1.5B |
| 总资产 | $397.6M | $2.2B |
| 负债/权益比越低杠杆越低 | 0.27× | 0.19× |
8季度趋势，按日历期对齐
现金及短期投资HBBLFST
| Q4 25 | $47.3M | $248.6M | ||
| Q3 25 | $17.2M | $203.9M | ||
| Q2 25 | $11.3M | $188.9M | ||
| Q1 25 | $48.3M | $134.3M | ||
| Q4 24 | $45.6M | $154.6M | ||
| Q3 24 | $22.6M | $102.6M | ||
| Q2 24 | $37.2M | $87.0M | ||
| Q1 24 | $26.3M | $49.5M |
总债务HBBLFST
| Q4 25 | $50.0M | $282.8M | ||
| Q3 25 | — | $284.6M | ||
| Q2 25 | — | $286.4M | ||
| Q1 25 | — | $288.2M | ||
| Q4 24 | $50.0M | $290.0M | ||
| Q3 24 | — | $287.3M | ||
| Q2 24 | — | $288.0M | ||
| Q1 24 | — | $288.8M |
股东权益HBBLFST
| Q4 25 | $182.8M | $1.5B | ||
| Q3 25 | $164.0M | $1.5B | ||
| Q2 25 | $164.0M | $1.5B | ||
| Q1 25 | $163.2M | $1.5B | ||
| Q4 24 | $165.9M | $1.4B | ||
| Q3 24 | $150.0M | $1.4B | ||
| Q2 24 | $145.7M | $1.4B | ||
| Q1 24 | $145.4M | $1.4B |
总资产HBBLFST
| Q4 25 | $397.6M | $2.2B | ||
| Q3 25 | $392.4M | $2.1B | ||
| Q2 25 | $363.8M | $2.1B | ||
| Q1 25 | $418.0M | $2.1B | ||
| Q4 24 | $415.1M | $2.1B | ||
| Q3 24 | $408.7M | $2.1B | ||
| Q2 24 | $369.9M | $2.1B | ||
| Q1 24 | $368.9M | $2.1B |
负债/权益比HBBLFST
| Q4 25 | 0.27× | 0.19× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | 0.30× | 0.20× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.20× | ||
| Q1 24 | — | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.5M | $57.6M |
| 自由现金流经营现金流 - 资本支出 | $27.9M | $46.6M |
| 自由现金流率自由现金流/营收 | 13.1% | 12.2% |
| 资本支出强度资本支出/营收 | 0.3% | 2.9% |
| 现金转化率经营现金流/净利润 | 1.53× | 4.93× |
| 过去12个月自由现金流最近4个季度 | $11.0M | $110.0M |
8季度趋势，按日历期对齐
经营现金流HBBLFST
| Q4 25 | $28.5M | $57.6M | ||
| Q3 25 | $9.1M | $27.3M | ||
| Q2 25 | $-30.4M | $64.4M | ||
| Q1 25 | $6.6M | $-3.1M | ||
| Q4 24 | $30.2M | $62.3M | ||
| Q3 24 | $-1.9M | $22.7M | ||
| Q2 24 | $17.4M | $44.1M | ||
| Q1 24 | $19.7M | $-21.8M |
自由现金流HBBLFST
| Q4 25 | $27.9M | $46.6M | ||
| Q3 25 | $8.4M | $17.0M | ||
| Q2 25 | $-31.3M | $56.6M | ||
| Q1 25 | $6.1M | $-10.3M | ||
| Q4 24 | $29.4M | $56.0M | ||
| Q3 24 | $-2.7M | $17.7M | ||
| Q2 24 | $16.8M | $39.0M | ||
| Q1 24 | $18.8M | $-26.9M |
自由现金流率HBBLFST
| Q4 25 | 13.1% | 12.2% | ||
| Q3 25 | 6.3% | 4.7% | ||
| Q2 25 | -24.5% | 16.4% | ||
| Q1 25 | 4.6% | -3.1% | ||
| Q4 24 | 13.8% | 17.2% | ||
| Q3 24 | -1.7% | 5.7% | ||
| Q2 24 | 10.7% | 12.5% | ||
| Q1 24 | 14.6% | -9.0% |
资本支出强度HBBLFST
| Q4 25 | 0.3% | 2.9% | ||
| Q3 25 | 0.6% | 2.8% | ||
| Q2 25 | 0.7% | 2.2% | ||
| Q1 25 | 0.4% | 2.2% | ||
| Q4 24 | 0.4% | 1.9% | ||
| Q3 24 | 0.5% | 1.6% | ||
| Q2 24 | 0.4% | 1.6% | ||
| Q1 24 | 0.7% | 1.7% |
现金转化率HBBLFST
| Q4 25 | 1.53× | 4.93× | ||
| Q3 25 | 5.52× | 25.34× | ||
| Q2 25 | -6.83× | — | ||
| Q1 25 | 3.67× | -4.36× | ||
| Q4 24 | 1.26× | — | ||
| Q3 24 | -0.98× | — | ||
| Q2 24 | 2.90× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HBB
| Consumer Product | $191.6M | 90% |
| Commercial Product | $17.5M | 8% |
| Health Beacon | $2.3M | 1% |
LFST
暂无分部数据
